Given this background and considering the substantial role of IEM disturbances in TB pathophysiology, we sought to investigate the relationship of PPARγ with some IEM components in the setting of clinical pulmonary TB, at the time of diagnosis and throughout the course of specific treatment to get a better understanding on their implication in the processes dealing with disease development and resolution. This evidence concerns the gene PPARG and pulmonary tuberculosis.